Fann W E
J Gerontol. 1976 May;31(3):304-10. doi: 10.1093/geronj/31.3.304.
Treatment of depression in elderly patients is not generically different from treatment of depression in younger age cohorts. Because of certain age-related physical, physiological, and biochemical factors, however, drug prescription for geriatric patients must be modified in several respects. Tricyclic antidepressants are the principal agents in treatment, but their side effects tend to be magnified in the elderly. Dosage should initially be lower than with younger patients and increased in gradual increments. Lithium, MAO inhibitors, and neuroleptics are appropriate in some cases, but additional precautions are necessary. Because the elderly are liable to multiple system decompensation, they are likely to be prescribed multiple pharmacological agents. Drug-drug interactions involving antidepressant medication present a variety of therapeutic problems and can threaten life. Depression in late life can be treated pharmacologically, but both the therapeutic and deleterious activities of the drugs can be altered by compromised organ systems.
老年患者抑郁症的治疗与年轻人群体抑郁症的治疗在一般情况下并无不同。然而,由于某些与年龄相关的身体、生理和生化因素,老年患者的药物处方必须在几个方面进行调整。三环类抗抑郁药是治疗的主要药物,但其副作用在老年人中往往会被放大。初始剂量应低于年轻患者,并逐步增加。锂盐、单胺氧化酶抑制剂和抗精神病药物在某些情况下适用,但需要采取额外的预防措施。由于老年人容易出现多系统失代偿,他们可能会被开具多种药物。涉及抗抑郁药物的药物相互作用会带来各种治疗问题,并可能危及生命。老年期抑郁症可以通过药物治疗,但药物的治疗和有害作用都可能因器官系统功能受损而改变。